HC Wainwright & Co. Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $3
Benzinga Newsdesk 2 years ago
NewsPrice TargetInitiationAnalyst Ratings
HC Wainwright & Co. analyst Yi Chen initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $3.
HC Wainwright & Co. analyst Yi Chen initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $3.